• 1
    Lehtinen JM, Uusitupa M, Sitonen O & Pyörälä K. Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects. Diabetes 1989; 38: 130713.
  • 2
    Uusitupa M, Siitonen O, Aro A & Pyörälä K. Prevalence of coronary heart disease, left ventricular failure and hypertension in middle aged newly diagnosed type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 1985; 28: 2227.
  • 3
    Midthjell K, Bjørndal A, Holmen J, Krüger Ø & Bjartveit K. Prevalence of known and previously unknown diabetes mellitus and impaired glucose tolerance in an adult Norwegian population. Indications of an increasing diabetes prevalence. The Nord-Trøndelag Diabetes Study. Scand J Prim Health Care 1995; 13: 22935.
  • 4
    Holmen J, Midthjell K & Bjartveit K et al. The Nord-Trøndelag Health Survey 1984–86. Purpose, background and methods. Participation, non-participation and frequency distributions. Report No. 4/1990. Verdal: National Institute of Public Health, Community Medicine Research Centre, 1990.
  • 5
    WHO Expert Committee on Diabetes Mellitus. Second report. Technical Report Series No. 646. Geneva: World Health Organization, 1980.
  • 6
    Fuller JH, Shipley MJ, Rose G, Jarrett RJ & Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycemia: the Whitehall study. Br Med J 1983; 287: 86770.
  • 7
    Kannel WB & McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham study. Diabetes Care 1989; 12: 46474.
  • 8
    WHO Study Group. Prevention of diabetes mellitus. Report of a WHO study group. Technical Report Series No. 844. Geneva: WHO, 1994.
  • 9
    Becks PJ, Mackaay AJC, DeNelling KND, DeVries H, Bouter LM & Heine RJ. Peripheral arterial disease in relation to glycemic level in an elderly Caucasian population: the Hoorn Study. Diabetologia 1995; 38: 8696.DOI: 10.1007/s001250050257
  • 10
    Damsgaard EM, Frøland A, Jørgensen OD & Mogensen CE. Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int 1992; 41: 73135.
  • 11
    Yudkin JS, Forrest RD & Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988; 2: 53033.
  • 12
    Gall A-M, Hougaard P, Borch-Johnsen K & Parving H-H. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: a prospective, observational study. Br Med J 1997; 314: 78388.
  • 13
    Perry IJ, Wannamethee G, Walker MK, Thomson AG, Whincup PH & Shaper AG. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. Br Med J 1995; 310: 56064.
  • 14
    Harris MI. Impaired glucose tolerance in the US population. Diabetes Care 1989; 12: 46474.
  • 15
    Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E & Pyörälä K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993; 36: 117584.
  • 16
    Harris MI, Klein R, Welborn TA & Knuiman MW. Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 1992; 15: 81519.
  • 17
    Hetlevik I, Holmen J, Krüger Ø & Holen A. Fifteen years with clinical guidelines in the treatment of hypertension – still discrepancies between intentions and practice. Scand J Prim Health Care 1997; 15: 13440.
  • 18
    Reaven GM. Role of insulin resistence in human medicine. Diabetes 1988; 37: 1595607.
  • 19
    Hanefeld M, Fischer S & Schmechel H et al. Diabetes intervention study. Multi-intervention trial in newly diagnosed NIDDM. Diabetes Care 1991; 14: 30817.